Biopharma Solutions

Discover the first high parameter, single-cell technology capable of defining subsets of powerful multi-functional, protein secreting cells that can determine and help predict response vs non-response or disease progression.

Uncover Solutions in Complex Patient Response

Use IsoPlexis’ Precision Profiling™ platform to capture the end function of thousands of single cells using our proprietary Isocode chip (SCBC), to discover new information in immunotherapy, CAR-T and TCR-T product characterization, predictive clinical biomarkers and checkpoint therapy. 

CAR-T Clinical Response Biomarker Discovery

Precision Profiling™ has shown that highly functional subsets of cytokine response may provide strong predictive biomarkers of clinical response.

CAR-T Product Characterization and Manufacturing

To ensure consistent manufacturing and improved outcomes, T-cell secretomic Precision Profiling™ can determine cellular and donor heterogeneity of CAR-T products.

TCR-T Product Analysis and Patient Monitoring

The IsoCode chip and IsoPlexis software combine to detect engineered T-cell therapy patient relapse, and elucidate cell immunotherapy patient response.

Checkpoint Biomarkers for Mechanism and Monitoring

Isoplexis’ single cell profiling of tumor-infiltrating T-cells has shown the potential to characterize patient response to Anti-PD-1 therapy.

Tumor Signaling for Combination Therapy Design

Use IsoPlexis' tumor-signaling analysis platform to predict drug resistance and inform better therapeutic intervention during preclinical drug development

Metabolomic Tumor Cellular Profiling

Monitor energy transfer and consumption in cancer to determine metabolic phenotypes, providing important information about tumorigenesis.

Collaborate with Us

IsoPlexis technology can offer breakthrough clinical insights and enable improved targeting of complex treatments to the patients who need them most.

Please email us to learn more about how IsoPlexis can help your organization solve today’s toughest health care problems.